Antibiotic intermediates (6-APA, 7-ACA): Regulation

Why penicillin plants must stand apart from other drugs

What this tab covers How it is regulated and what could disrupt supply: hazard classification, rules in the EU, US and India, anti-dumping duties and other trade measures, and supply-risk notes.

Hazards

Classification	UN number	Key risks
respiratory sensitisation cat 1, skin sensitisation cat 1 (penicillins)	not regulated	Penicillin allergy means beta-lactams must be made in segregated facilities.

Main rules

Where	Rule	Effect
US	21 CFR 211.42(d) and FDA guidance require separate facilities for penicillin and cephalosporin products	dedicated plants raise capital cost
Global	AMR Industry Alliance antibiotic manufacturing standard (discharge limits)	pressure on effluent from fermentation and API sites

India

Rule	Effect
PLI fermentation category: incentive of 20% of sales in early years	made Lyfius viable
MIP via DGFT (Jan 2026)	floor price on imports for one year
CPCB effluent standards; draft antibiotic residue limits	tighter effluent rules (indicative)

Trade measures

MIP on penicillin G, 6-APA, amoxicillin (2026)
DGTR anti-dumping: penicillin G (China), 6-APA (China, EU), amoxicillin trihydrate (China), Sept 2026

Supply risk

One of the most concentrated pharma chains: China supplies most world penicillin G, 6-APA and 7-ACA. Several governments list beta-lactam intermediates as strategic.